On the afternoon of November 30, the 2023 Nanshan District Enterprise High-Quality Development Exchange, hosted by the Nanshan Bureau of the Shenzhen Market Supervision Administration and organized by the Shenzhen Quality Strong City Promotion Association, was successfully held. Themed "Build a high-quality ecosystem to support the upgrading of enterprise quality and brands", the event invited senior experts in quality, standardization, intellectual property, and digitalization, as well as several well-known Nanshan-based entrepreneurs, to share their insights in depth. Dr. Hu Junyuan, Chairman of Beike Biotech, was invited to attend the roundtable dialogue, where he discussed the topic of high-quality enterprise development with the other guests.
Building a quality-strong country is an important measure for promoting high-quality development and supporting China's transition from a large economy to a strong one. Shenzhen's Nanshan District, as both a major economic district and a strong innovation district, is undoubtedly a key engine and important carrier in helping Shenzhen build a high-quality development hub. By inviting representatives from across sectors to discuss high-quality development, this event aimed to build on past success — summarizing and sharing good experience, spreading and sharing wisdom, and jointly opening a new chapter. At the event, several senior industry experts, university professors, and entrepreneurs delivered keynote speeches on quality management innovation and other topics. In addition, Guo Xiaoyu, former Inspector of the Shenzhen Market Supervision Administration; Liu Wantao, Executive President of the Shenzhen Quality Strong City Promotion Association; Hu Junyuan, Chairman of Shenzhen Beike Biotechnology Co., Ltd.; Sun Xiaoli, Chairman of Shenzhen Hekoumei Food Co., Ltd.; and Cui Yibin, President of Vertiv Technology Co., Ltd., engaged in a dialogue around "How to empower high-quality enterprise development through a high-quality ecosystem", discussing and exchanging views from multiple dimensions including quality infrastructure construction, government guidance, enterprise initiative, and the supporting role of social organizations.
In the dialogue, Dr. Hu Junyuan noted that as the new round of technological revolution and industrial transformation deepens, profound changes are taking place in quality concepts and mechanism innovation. Faced with the current wave of intelligence and digitalization, as a frontier area in biotechnology, Beike Biotech has consistently focused on the path of intelligent transformation in cell R&D innovation and standardized cell production. Driven by both AI and innovative R&D, the company is working to nurture new enterprise advantages centered on technology, standards, brand, quality, and service; actively benchmarking against advanced international technologies, rules, and standards; comprehensively enhancing product strength and brand strength; and striving to become an industry exemplar of high-quality development for China's domestic cell sector.
